Literature DB >> 15983263

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.

Peter Libby1, David M Nathan, Kristin Abraham, John D Brunzell, Judith E Fradkin, Steven M Haffner, Willa Hsueh, Marian Rewers, B Tibor Roberts, Peter J Savage, Sonia Skarlatos, Momtaz Wassef, Cristina Rabadan-Diehl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15983263     DOI： 10.1161/CIRCULATIONAHA.104.529651

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  110 in total

1.  Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes.

Authors:  Raju V S R K Gottumukkala; HuiJuan Lv; Lizbeth Cornivelli; Amy J Wagers; Raymond Y Kwong; Roderick Bronson; Garrick C Stewart; P Christian Schulze; William Chutkow; Howard A Wolpert; Richard T Lee; Myra A Lipes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

Review 2.  Cardiovascular risk and prevention in diabetes mellitus.

Authors:  Aled W Roberts
Journal:  Clin Med (Lond)       Date:  2010-10       Impact factor: 2.659

Review 3.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

4.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Authors:  Theodore Mazzone
Journal:  Circulation       Date:  2010-11-23       Impact factor: 29.690

Review 5.  The good fat hormone: adiponectin and cardiovascular disease.

Authors:  Dat Do; Jorge Alvarez; Elaine Chiquette; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

Review 6.  Regulating myocardial blood flow in health and disease.

Authors:  Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

7.  Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation.

Authors:  Xiangbin Xu; Bong Sook Jhun; Chang Hoon Ha; Zheng-Gen Jin
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 8.  Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Authors:  Anthony S Wierzbicki; Adie Viljoen
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

9.  Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.

Authors:  Sridevi Devaraj; Ishwarlal Jialal
Journal:  Cytokine       Date:  2009-05-15       Impact factor: 3.861

10.  Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes.

Authors:  A Riad; D Westermann; S Van Linthout; Z Mohr; S Uyulmaz; P M Becher; H Rütten; P Wohlfart; H Peters; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2008-09-30       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.